August 04, 2023
In re: Abbott Laboratories, et al
Case Number:
23-2412
Court:
Nature of Suit:
Companies
- Abbott Laboratories
- AbbVie Inc.
- Allergan PLC
- Cardinal Health Inc.
- Cencora Inc.
- J.M. Smith Corp.
- McKesson Corp.
- Paddock Laboratories Inc.
- Par Pharmaceutical Cos. Inc.
- Teva Pharmaceutical Industries Ltd.
- The Harvard Drug Group LLC
Sectors & Industries:
View recent docket activity
Reflects complaints, answers, motions, orders and trial notes entered from Jan. 1, 2011.
Additional or older documents may be available in Pacer.
Coverage
-
March 25, 2024
3rd Circ. Won't Rethink AbbVie Privilege Ruling
The Third Circuit refused Monday to reconsider a ruling that found AbbVie was unable to show a lower court went against precedent or made errors when ordering the drugmaker to turn over attorney communications from a patent case allegedly meant to delay an AndroGel rival.
Parties
Stay ahead of the curve
In the legal profession, information is the key to success. You have to know what’s happening with clients, competitors, practice areas, and industries. Law360 provides the intelligence you need to remain an expert and beat the competition.
- Direct access to case information and documents.
- All significant new filings across U.S. federal district courts, updated hourly on business days.
- Full-text searches on all patent complaints in federal courts.
- No-fee downloads of the complaints and so much more!
TRY LAW360 FREE FOR SEVEN DAYS
Already a subscriber? Click here to login